PHARMACIE ROYALE-BOTANIQUE financials
A multi-period view of the public annual-account figures reported for PHARMACIE ROYALE-BOTANIQUE, with comparable measures and links to available source documents.
Company overviewRegistry number
0818921312
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for PHARMACIE ROYALE-BOTANIQUE
2025 versus 2024
- Operating line
- €116,358
- EBITDA
- -€41,083
- Total assets
- €649,343
- Equity
- €607,035
-45.1%
-223%
-17.9%
-7.9%
EBITDA margin -35.3% · Equity ratio +93.5%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €116,358 | -€41,083 | €649,343 | €607,035 | - |
| 202431 Dec 2024 | €211,823 | €33,399 | €791,107 | €658,834 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.